Gentle Warriors Academy Healthy Marriage and Responsible Fatherhood Program Evaluation
Launched by MIDWEST EVALUATION & RESEARCH · Mar 21, 2025
Trial Information
Current as of April 22, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This study is a descriptive evaluation of the Gentle Warriors Academy program offered to fathers in the Atlanta metropolitan area. Program participants are informed about the study and asked to provide consent to participate in the evaluation of the program. Consenting participants complete surveys at program enrollment, program exit, and 12 months after program enrollment, and survey data is used to determine if the program is associated with short-term and long-term changes in attitudes and behaviors among participants. Changes in parenting attitudes and parental well-being are assessed b...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Adult (age 18-55)
- • Father/father figure
- • With children under age 16
- • Reside in Metro Atlanta area
- Exclusion Criteria:
- • Minor (under the age of 18)
- • Not a father/father figure
- • Children older than 16 years old
- • Reside outside of Metro Atlanta area
Trial Officials
Matt D Shepherd, PhD
Principal Investigator
Midwest Evaluation and Research
About Midwest Evaluation & Research
Midwest Evaluation & Research is a dedicated clinical trial sponsor focused on advancing medical knowledge and improving patient outcomes through innovative research. With a commitment to rigor and integrity, the organization collaborates with healthcare professionals, regulatory bodies, and community stakeholders to design and conduct high-quality clinical studies across various therapeutic areas. Leveraging a team of experienced researchers and state-of-the-art methodologies, Midwest Evaluation & Research aims to contribute valuable insights to the medical field while ensuring the highest standards of ethical practice and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
